Incidence of carcinoma of the major salivary glands according to the WHO classification, 1992 to 2006: A population-based study in the United States

Cancer Epidemiology Biomarkers and Prevention

Volumn 18, Issue 11, 2009, Pages 2899-2906

  Boukheris, Houda ^a   Curtis, Rochelle E ^a   Land, Charles E ^a   Dores, Graça M ^a,b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACINAR CELL CARCINOMA; ADENOID CYSTIC CARCINOMA; ADENOSQUAMOUS CARCINOMA; ADULT; AFRICAN AMERICAN; AGED; ARTICLE; ASIAN AMERICAN; BASAL CELL CARCINOMA; CANCER CLASSIFICATION; CANCER INCIDENCE; CARCINOSARCOMA; CLEAR CELL CARCINOMA; CYSTADENOCARCINOMA; EUROPEAN AMERICAN; FEMALE; HUMAN; LARGE CELL CARCINOMA; LYMPHOEPITHELIOMA; MAJOR CLINICAL STUDY; MALE; MUCINOUS CARCINOMA; PACIFIC ISLANDER; PAROTID GLAND; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; SALIVARY GLAND CARCINOMA; SEBACEOUS CARCINOMA; SMALL CELL CARCINOMA; SQUAMOUS CELL CARCINOMA; SUBMANDIBULAR GLAND; UNITED STATES; WORLD HEALTH ORGANIZATION;

ADOLESCENT; ADULT; AGED; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; RISK FACTORS; SALIVARY GLAND NEOPLASMS; SEER PROGRAM; UNITED STATES; WORLD HEALTH ORGANIZATION; YOUNG ADULT;

EID: 72749083394     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-09-0638     Document Type: Article

References (40)

1. Horner MJ, Ries LAG, Krapcho M, et al. SEER cancer statistics review, 1975-2006. Bethesda (MD): National Cancer Institute; 2009.
2. Davies L, Welch HG. Epidemiology of head and neck cancer in the United States. Otolaryngol Head Neck Surg 2006;135:451-457
3. Barnes LB, Eveson JW, Reichart P, Sidransky D, editors. Pathology and genetics of head and neck tumors. Lyon: IARC Press; 2005.
4. Foote FW, Jr., Frazell EL. Tumors of the major salivary glands. Cancer 1953;6:1065-1133
5. Speight PM, Barrett AW. Salivary gland tumours. Oral Dis 2002;8: 229-240
6. Mayne ST, Morse DE, Winn DM. Cancers of the oral cavity and pharynx. Cancer Epidemiol Biomarkers Prev, 674-696 New York: Oxford University Press; 2006.
7. Land CE, Saku T, Hayashi Y, et al. Incidence of salivary gland tumors among atomic bomb survivors, 1950-1987. Evaluation of radiation-related risk. Radiat Res 1996;146:28-36.
8. Ellis GL, Auclair PL. Tumors of the salivary glands. Washington (DC): Armed Forces Institute of Pathology; 2008.
9. Eneroth CM. Salivary gland tumors in the parotid gland, submandibular gland, and the palate region. Cancer 1971;27:1415-1418
10. Eveson JW, Cawson RA. Salivary gland tumours. A review of 2410 cases with particular reference to histological types, site, age and sex distribution. J Pathol 1985;146:51-58
11. Jones AV, Craig GT, Speight PM, Franklin CD. The range and demographics of salivary gland tumours diagnosed in a UK population. Oral Oncol 2008;44:407-417
12. Spiro RH. Salivary neoplasms: overview of a 35-year experience with 2,807 patients. Head Neck Surg 1986;8:177-184
13. Horn-Ross PL, West DW, Brown SR. Recent trends in the incidence of salivary gland cancer. Int J Epidemiol 1991;20:628-633
14. Luukkaa H, Klemi P, Leivo I, et al. Salivary gland cancer in Finland 1991-1996: an evaluation of 237 cases. Acta Otolaryngol 2005;125:207-214
15. Ostman J, Anneroth G, Gustafsson H, Tavelin B. Malignant salivary gland tumours in Sweden 1960-1989 - an epidemiological study. Oral Oncol 1997;33:169-176
16. O'Sullivan EM. International variation in the incidence of oral and pharyngeal cancer. Community Dent Health 2008;25:148-153
17. Sun EC, Curtis R, Melbye M, Goedert JJ. Salivary gland cancer in the United States. Cancer Epidemiol Biomarkers Prev 1999;8:1095-1100 (Pubitemid 30004907)
18. Wahlberg P, Anderson H, Biorklund A, Moller T, Perfekt R. Carcinoma of the parotid and submandibular glands - a study of survival in 2465 patients. Oral Oncol 2002;38:706-713 (Pubitemid 34880110)
19. Muir C, Weiland L. Upper aerodigestive tract cancers. Cancer 1995;75: 147-153
20. Surveillance, Epidemiology and End Results (SEER) Program SEER*Stat Database: Incidence - SEER-13 Regs Public-Use, Nov 2008 Sub (1992-2006), National Cancer Institute DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2009, based on the November 2008 submission.
21. Fritz A, Percy C, Jack A, et al. International Classification of Diseases for Oncology. Geneva (Switzerland): WHO; 2000.
22. Percy C, Van Holten V, Muir C. International Classification of Diseases for Oncology. Geneva (Switzerland): WHO; 1990.
23. Devesa SS, Donaldson J, Fears T. Graphical presentation of trends in rates. Am J Epidemiol 1995;141:300-304
24. Spitz MR, Batsakis JG. Major salivary gland carcinoma. Descriptive epidemiology and survival of 498 patients. Arch Otolaryngol 1984; 110:45-49
25. Kolude B, Lawoyin JO, Akang EE. Salivary gland neoplasms: a 21 year review of cases seen at University College Hospital, Ibadan. Afr J Med Med Sci 2001;30:95-98
26. Onyango JF, Awange DO, Muthamia JM, Muga BI. Salivary gland tumours in Kenya. East Afr Med J 1992;69:525-530
27. Gail M, Simon R. Testing for qualitative interactions between treatment effects and patient subsets. Biometrics 1985;41:361-372
28. Horn-Ross PL, Morrow M, Ljung BM. Menstrual and reproductive factors for salivary gland cancer risk in women. Epidemiology 1999; 10:528-530 (Pubitemid 29398909)
29. Spitz MR, Tilley BC, Batsakis JG, Gibeau JM, Newell GR. Risk factors for major salivary gland carcinoma. A case-comparison study. Cancer 1984;54:1854-1859
30. Flynn MB, Maguire S, Martinez S, Tesmer T. Primary squamous cell carcinoma of the parotid gland: the importance of correct histological diagnosis. Ann Surg Oncol 1999;6:768-770 (Pubitemid 30013654)
31. Ying YL, Johnson JT, Myers EN. Squamous cell carcinoma of the parotid gland. Head Neck 2006;28:626-632 (Pubitemid 44025112)
32. Bergersen PJ, Kennedy PJ, Kneale KL. Metastatic tumours of the parotid region. Aust N Z J Surg 1987;57:23-26
33. Nuyens M, Schupbach J, Stauffer E, Zbaren P. Metastatic disease to the parotid gland. Otolaryngol Head Neck Surg 2006;135:844-848
34. Eveson JW. Troublesome tumours 2: borderline tumours of salivary glands. J Clin Pathol 1992;45:369-377
35. Kamangar F, Dores GM, Anderson WF. Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol 2006;24:2137-2150 (Pubitemid 46655601)
36. Hayes RB, Bravo-Otero E, Kleinman DV, et al. Tobacco and alcohol use and oral cancer in Puerto Rico. Cancer Causes Control 1999;10:27-33. (Pubitemid 29134749)
37. Sadetzki S, Oberman B, Mandelzweig L, et al. Smoking and risk of parotid gland tumors: a nationwide case-control study. Cancer 2008; 112:1974-1982 (Pubitemid 351574073)
38. Muscat JE, Wynder EL. A case/control study of risk factors for major salivary gland cancer. Otolaryngol Head Neck Surg 1998;118:195-198 (Pubitemid 28093307)
39. Spitz MR, Fueger JJ, Goepfert H, Newell GR. Salivary gland cancer. A case-control investigation of risk factors. Arch Otolaryngol Head Neck Surg 1990;116:1163-1166
40. Canto MT, Devesa SS. Oral cavity and pharynx cancer incidence rates in the United States, 1975-1998. Oral Oncol 2002;38:610-617